197 related articles for article (PubMed ID: 14533979)
21. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
22. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells.
Rozanov DV; Hahn-Dantona E; Strickland DK; Strongin AY
J Biol Chem; 2004 Feb; 279(6):4260-8. PubMed ID: 14645246
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities.
Tam EM; Moore TR; Butler GS; Overall CM
J Biol Chem; 2004 Oct; 279(41):43336-44. PubMed ID: 15292230
[TBL] [Abstract][Full Text] [Related]
24. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
[TBL] [Abstract][Full Text] [Related]
25. Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis.
Belkin AM; Zemskov EA; Hang J; Akimov SS; Sikora S; Strongin AY
Biochemistry; 2004 Sep; 43(37):11760-9. PubMed ID: 15362860
[TBL] [Abstract][Full Text] [Related]
26. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
27. Influence of oleic acid on the expression, activation and activity of gelatinase A produced by oncogene-transformed human bronchial epithelial cells.
Polette M; Huet E; Birembaut P; Maquart FX; Hornebeck W; Emonard H
Int J Cancer; 1999 Mar; 80(5):751-5. PubMed ID: 10048978
[TBL] [Abstract][Full Text] [Related]
28. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).
English WR; Velasco G; Stracke JO; Knäuper V; Murphy G
FEBS Lett; 2001 Feb; 491(1-2):137-42. PubMed ID: 11226436
[TBL] [Abstract][Full Text] [Related]
29. The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP).
Remacle AG; Rozanov DV; Baciu PC; Chekanov AV; Golubkov VS; Strongin AY
J Cell Sci; 2005 Nov; 118(Pt 21):4975-84. PubMed ID: 16219679
[TBL] [Abstract][Full Text] [Related]
30. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
[TBL] [Abstract][Full Text] [Related]
31. The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.
Lee MH; Atkinson S; Rapti M; Handsley M; Curry V; Edwards D; Murphy G
Cancer Lett; 2010 Apr; 290(1):114-22. PubMed ID: 19815335
[TBL] [Abstract][Full Text] [Related]
32. Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis.
Holtz B; Cuniasse P; Boulay A; Kannan R; Mucha A; Beau F; Basset P; Dive V
Biochemistry; 1999 Sep; 38(37):12174-9. PubMed ID: 10508422
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
Yamamoto M; Tsujishita H; Hori N; Ohishi Y; Inoue S; Ikeda S; Okada Y
J Med Chem; 1998 Apr; 41(8):1209-17. PubMed ID: 9548812
[TBL] [Abstract][Full Text] [Related]
34. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
35. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
36. Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo.
Nonaka T; Nishibashi K; Itoh Y; Yana I; Seiki M
Mol Cancer Ther; 2005 Aug; 4(8):1157-66. PubMed ID: 16093431
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
Bai S; Thummel R; Godwin AR; Nagase H; Itoh Y; Li L; Evans R; McDermott J; Seiki M; Sarras MP
Matrix Biol; 2005 Jun; 24(4):247-60. PubMed ID: 15935631
[TBL] [Abstract][Full Text] [Related]
38. The Catalytic Domain Mediates Homomultimerization of MT1-MMP and the Prodomain Interferes with MT1-MMP Oligomeric Complex Assembly.
Fogarasi M; Dima S
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009039
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic trypsin activates human promatrix metalloproteinase-2.
Lindstad RI; Sylte I; Mikalsen SO; Seglen PO; Berg E; Winberg JO
J Mol Biol; 2005 Jul; 350(4):682-98. PubMed ID: 15950241
[TBL] [Abstract][Full Text] [Related]
40. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
